Singapore: According to Millennium Research Group (MRG), a provider of market intelligence on medical technology, the em...
Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, t...
Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thail...
Singapore: Scientists at Weill Cornell Medical College have discovered the molecular switch that allows aggressive tripl...
Singapore: Info Kinetics and Clinical Trial Center for Medical Devices of Yeungnam University Hospital, South Korea, sig...
Singapore: Samsung Electronics, US, has launched Samsung Financial Solutions, focused on facilitating funding and acquis...
Singapore: SK Biopharmaceuticals (SKBP) and Hamni Pharmaceutical have signed a licensing out agreement for SKBP's diazep...
Dong-A Pharmaceutical adopts innovative and flexible business models to achieve substantial revenues at the end of each ...
Singapore: EffRx Pharmaceuticals announced the signing of an exclusive distribution agreement with Ahn-Gook Pharmaceutic...
Singapore: As part of its strategy to further build global supply chain competence in the healthcare market, Germany-bas...
Singapore: ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical ...
Singapore: A new type of drug delivery system has been devised, which uses an erbium-doped yttrium aluminium garnet lase...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Josep...
Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...
Singapore: In a bid to generate new profit engines, South Korean pharmaceutical companies have set their eyes on oversea...
Singapore: OmniComm Systems, a provider of clinical data management solutions for clinical trials, has signed a five yea...